[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA cancer J Clin,2021,71(3):209-249.
[2] GNANT M,HARBECK N,THOMSSEN C.St.Gallen 2011:summary of the consensus discussion[J].Breast Care(Basel),2011,6(2):136-141.
[3] NIK-ZAINAL S,DAVIES H,STAAF J,et al.Landscape of somatic mutations in 560 breast cancer whole-genome sequences[J].Nature,2016,534(7605):47-54.
[4] MURAYAMA T,GOTOH N.Patient-derived xenograft models of breast cancer and their application[J].Cells,2019,8(6):E621.
[5] ILINA O,GRITSENKO P G,SYGA S,et al.Cell-cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion[J].Nat Cell Biol,2020,22(9):1103-1115.
[6] GOODSPEED A,HEISER L M,GRAY J W,et al.Tumor-derived cell lines as molecular models of cancer pharmacogenomics[J].Mol Cancer Res,2016,14(1):3-13.
[7] INVREA F,ROVITO R,TORCHIARO E,et al.Patient-derived xenografts(PDXs)as model systems for human cancer[J].Curr Opin Biotechnol,2020,63:151-156.
[8] DI RENZO M F,CORSO S.Patient-derived cancer models[J].Cancers(Basel),2020,12(12):3779.
[9] SCHUTGENS F,CLEVERS H.Human organoids:tools for understanding biology and treating diseases[J].Annu Rev Pathol,2020,15:211-234.
[10] SATO T,VRIES R G,SNIPPERT H J,et al.Single lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J].Nature,2009,459(7244):262-265.
[11] LI M,IZPISUA BELMONTE J C.Organoids-preclinical models of human disease[J].N Engl J Med,2019,380(6):569-579.
[12] BALLARD D H,BOYER C J,ALEXANDER J S.Organoids-preclinical models of human disease[J].N Engl J Med,2019,380(20):1981-1982.
[13] SATO T,STANGE D E,FERRANTE M,et al.Long-term expansion of epithelial organoids from human colon,adenoma,adenocarcinoma,and Barrett's epithelium[J].Gastroenterology,2011,141(5):1762-1772.
[14] BOJ S F,HWANG C I,BAKER L A,et al.Organoid models of human and mouse ductal pancreatic cancer[J].Cell,2015,160(1-2):324-338.
[15] PARK J W,LEE J K,PHILLIPS J W,et al.Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay[J].Proc Natl Acad Sci U S A,2016,113(16):4482-4487.
[16] BROUTIER L,MASTROGIOVANNI G,VERSTEGEN M M,et al.Human primary liver cancer-derived organoid cultures for disease modeling and drug screening[J].Nat Med,2017,23(12):1424-1435.
[17] MAZZUCCHELLI S,PICCOTTI F,ALLEVI R,et al.Establishment and morphological characterization of patient-derived organoids from breast cancer[J].Biol Proced Online,2019,21:12.
[18] TUVESON D,CLEVERS H.Cancer modeling meets human organoid technology[J].Science,2019,364(6444):952-955.
[19] VLACHOGIANNIS G,HEDAYAT S,VATSIOU A,et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J].Science,2018,359(6378):920-926.
[20] DEROSE Y S,GLIGORICH K M,WANG G,et al.Patient-derived models of human breast cancer:protocols for in vitro and in vivo applications in tumor biology and translational medicine[J].Curr Protoc Pharmacol,2013,14(23):1-43.
[21] ROST J,CLEVERS H.Organoids in cancer research[J].Nat Rev Cancer,2018,18(71):407-418.
[22] SACHS N,DELIGT J,KOPPER O,et al.A living biobank of breast cancer organoids captures disease heterogeneity[J].Cell,2018,172(10):373-386.
[23] DEKKERS J F,WHITTLE J R,VAILLANT F,et al.Modeling breast cancer using CRISPR-Cas9-mediated engineering of human breast organoids[J].J Natl Cancer Inst,2020,112(5):540-544.
[24] HEITINK L,WHITTLE J R,VAILLANT F,et al.In vivo genome-editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis[J].Mol Oncol,2022,16(5):1119-1131.
[25] CHEN J,ZHU J,XU S J,et al.Transmembrane 4L six family member 1 suppresses hormone receptor-positive,HER2-negative breast cancer cell proliferation[J].Front Pharmacol,2022,13:770993.
[26] BIANCO G,COTO-LLERENA M,GALLON J,et al.GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers[J].Commun Biol,2022,5(1):373.
[27] 王晨飞,胡浩霖,吕建鑫,等.乳腺癌侵袭相关分子的研究热点[J].东南大学学报(医学版),2018,37(4):734-738.
[28] WALSH A J,COOK R S,SANDERS M E,et al.Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer[J].Cancer Res,2014,74(18):5184-5194.
[29] MUKUNDAN S,BELL J,TERYEK M,et al.Automated assessment of cancer drug efficacy on breast tumor spheroids in AggrewellTM 400 plates using Image cytometry[J].J Fluoresc,2022,32(2):521-531.
[30] LI J,XU H,ZHANG L,et al.Malignant ascites-derived organoid(MADO)cultures for gastric cancer in vitro modelling and drug screening[J].J Cancer Res Clin Oncol,2019,145(11):2637-2647.
[31] 林嘉燕,张建国.乳腺癌新辅助化疗疗效的评估方法及其进展[J].东南大学学报(医学版),2019,38(4):727-731.
[32] PAN B,LI X,ZHAO D,et al.Optimizing individualized treatment strategy based on breast cancer organoid model[J].Clin Transl Med,2021,11(4):e380.
[33] NAGLE P W,PLUKKER J T M,MUIJS C T,et al.Patient-derived tumor organoids for prediction of cancer treatment response[J].Semin Cancer Biol,2018,53:258-264.
[34] YOSHIDA G J.Applications of patient-derived tumor xenograft models and tumor organoids[J].J Hematol Oncol,2020,13(1):4.
[35] BHATIA S,KRAMER M,RUSSO S,et al.Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics[J].Cancer Res,2022,82(7):1174-1192.
[36] SAORIN G,CALIGIURI I,RIZZOLIO F.Microfluidic organoids-on-a-chip:the future of human models[J].Semin Cell Dev Biol,2023,144:41-54.
[37] WANG Y Q,TAO T T,QIN J H.Organoids-on-a-chip(in Chinese)[J].Sci Sin Vitae,2023,53:211-220.
[38] LEE K K,MCCAULEY H A,BRODA T R,et al.Human stomach-on-a-chip with luminal flow and peristaltic-like motility[J].Lab Chip,2018,18(20):3079-3085.
[39] SKARDAL A,ALEMAN J,FORSYTHE S,et al.Drug compound screening in single and integrated multi-organoid body-on-a-chip systems[J].Biofabrication,2020,12(2):025017.
[40] TAO T T,WANG Y Q,CHEN W W,et al.Engineering human islet organoids from iPSCs using an organ-on-chip platform[J].Lab on a Chip,2019,19(6):948-958.
[41] PARK S E,GEORGESCU A,HUH D.Organoids-on-a-chip[J].Science,2019,364(6444):960-965.
[42] RONALDSON-BOUCHARD K,TELES D,YEAGER K,et al.A multi-organ chip with matured tissue niches linked by vascular flow[J].Nat Biomed Eng,2022,6(4):351-371.
[43] NIKOLAEV M,MITROFANOVA O,BROGUIERE N,et al.Homeostatic mini-intestines through scaffold-guided organoid morphogenesis[J].Nature,2020,585(7826):574-578. 《现代医学》唯一投稿网址:www.xdyx.org.cn |
